These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neurofibromatosis Type 1: Description of a Novel Diagnostic Scoring System in Pediatric Optic Nerve Glioma. Eid H; Crevier-Sorbo G; Aldraihem A; Menegotto F; Wilson N AJR Am J Roentgenol; 2019 Apr; 212(4):892-898. PubMed ID: 30741560 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of optic nerve diameters in individuals with neurofibromatosis and comparison of normative values in different pediatric age groups. Tosun M; Güngör M; Uslu H; Anık Y Clin Imaging; 2022 May; 85():83-88. PubMed ID: 35259715 [TBL] [Abstract][Full Text] [Related]
5. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859 [TBL] [Abstract][Full Text] [Related]
6. Comparison of multi-shot and single shot echo-planar diffusion tensor techniques for the optic pathway in patients with neurofibromatosis type 1. Ho CY; Deardorff R; Kralik SF; West JD; Wu YC; Shih CS Neuroradiology; 2019 Apr; 61(4):431-441. PubMed ID: 30684113 [TBL] [Abstract][Full Text] [Related]
7. Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1. Sellmer L; Farschtschi S; Marangoni M; Heran MKS; Birch P; Wenzel R; Mautner VF; Friedman JM Orphanet J Rare Dis; 2018 Apr; 13(1):62. PubMed ID: 29685181 [TBL] [Abstract][Full Text] [Related]
8. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1. Trevisson E; Cassina M; Opocher E; Vicenzi V; Lucchetta M; Parrozzani R; Miglionico G; Mardari R; Viscardi E; Midena E; Clementi M J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031 [TBL] [Abstract][Full Text] [Related]
9. Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma. Boonzaier NR; Hales PW; D'Arco F; Walters BC; Kaur R; Mankad K; Cooper J; Liasis A; Smith V; O'Hare P; Hargrave D; Clark CA Neuroimage Clin; 2020; 28():102447. PubMed ID: 33038669 [TBL] [Abstract][Full Text] [Related]
10. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital. Rony C; Aharoni S; Halevy A Neuropediatrics; 2022 Oct; 53(5):370-375. PubMed ID: 35381604 [TBL] [Abstract][Full Text] [Related]
11. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105 [TBL] [Abstract][Full Text] [Related]
12. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas. Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074 [TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas. Arnljots U; Nilsson M; Bolzani R; Benassi M; Sandvik U; Munoz DM; Blomgren K; Hellgren K PLoS One; 2024; 19(7):e0305548. PubMed ID: 38990917 [TBL] [Abstract][Full Text] [Related]
14. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1. Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in children. Marsault P; Ducassou S; Menut F; Bessou P; Havez-Enjolras M; Chateil JF Neuroradiology; 2019 Jun; 61(6):711-720. PubMed ID: 30904949 [TBL] [Abstract][Full Text] [Related]
16. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature. Friedrich RE; Nuding MA Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519 [TBL] [Abstract][Full Text] [Related]
18. Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1. Shaikh F; Johnston D; Michaud J; Hurteau J; Vassilyadi M; Keene D Pediatr Blood Cancer; 2011 Oct; 57(4):688-6690. PubMed ID: 21465640 [TBL] [Abstract][Full Text] [Related]
19. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma. Cambiaso P; Galassi S; Palmiero M; Mastronuzzi A; Del Bufalo F; Capolino R; Cacchione A; Buonuomo PS; Gonfiantini MV; Bartuli A; Cappa M; Macchiaiolo M Am J Med Genet A; 2017 Sep; 173(9):2353-2358. PubMed ID: 28631895 [TBL] [Abstract][Full Text] [Related]
20. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort. Blanchard G; Lafforgue MP; Lion-François L; Kemlin I; Rodriguez D; Castelnau P; Carneiro M; Meyer P; Rivier F; Barbarot S; Chaix Y; Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]